Dystonia Clinical Trial
Official title:
Suppression and Facilitation of the Motor Cortex by Stimulation of the Cerebellum in Patients With Dystonia and Healthy Controls
This study will examine the role of certain areas of the brain in blepharospasm, a type of
dystonia (abnormality of movement and muscle tone) that causes unwanted or uncontrollable
blinking or closing of the eyelids. The study will compare brain activity in healthy
volunteers and in people with blepharospasm to find differences in the brain that may lead to
better treatments for dystonia.
Healthy volunteers and people with blepharospasm who are 18 years of age and older may be
eligible for this study. All candidates are screened with a medical history. People with
blepharospasm also have a physical examination and blepharospasm rating.
Participants undergo transcranial magnetic stimulation (TMS) and electromyography (EMG) in
two 4-hour sessions, separated by 1 to 7 days.
TMS
A wire coil is held on the subject s scalp. A brief electrical current is passed through the
coil, creating a magnetic pulse that stimulates the brain. The subject hears a click and may
feel a pulling sensation on the skin under the coil. There may be a twitch in muscles of the
face, arm or leg. During the stimulation, subjects may be asked to tense certain muscles
slightly or perform other simple actions. Repetitive TMS involves repeated magnetic pulses
delivered in short bursts of impulses. Subjects receive 60 pulses per minute over 15 minutes.
EMG
Surface EMG is done during TMS to measure the electrical activity of muscles. For this test,
electrodes (small metal disks) are filled with a conductive gel and taped to the skin of the
face.
Objective
Besides alterations in the basal ganglia, substantial evidence identifies cerebellar
dysfunction as a possible cause for dystonia. Pathophysiological findings suggest that the
cerebellar influence on the primary motor cortex is modified in patients with different forms
of dystonia. The objective of this study is to find out whether this cerebellar influence
plays a role in dystonic disorders.
Study population
20 patients with blepharospasm, 20 patients with focal hand dystonia, 20 patients with DYT-1
Primary generalized dystonia and 60 healthy volunteers age and sex matched.
Design
Paired pulse transcranial magnetic stimulation (TMS) will be performed at rest and during
tonic activation of the first dorsal interosseus muscle (FDI). The conditioning stimulus (CS)
will be applied to the ipsilateral cerebellum using different intensities and will precede
the test stimulus by intervals from 3 to 10 ms, respectively. The test stimulus (TS) will be
applied over the motor hot spot of FDI in the primary motor cortex.
Outcome measures
The primary outcome measure will be the motor evoked potential (MEP) in FDI after a
conditioning cerebellar stimulus in relation to the unconditioned MEP size. Each different
patient group will be compared separately to the age- and sex-matched healthy controls and
between each other. Secondary outcome parameters will be the influence of different
interstimulus intervals and different stimulation intensities of the conditioning stimulus on
the MEP.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01433757 -
Ampicillin for DYT-1 Dystonia Motor Symptoms
|
Phase 1 | |
Recruiting |
NCT00971854 -
Alteration of Deep Brain Stimulation Parameters for Dystonia
|
N/A | |
Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
Completed |
NCT00169338 -
Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia
|
Phase 2 | |
Completed |
NCT00004421 -
Deep Brain Stimulation in Treating Patients With Dystonia
|
Phase 2/Phase 3 | |
Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
Recruiting |
NCT02583074 -
Clinical Trial of STN-DBS for Primary Cranial-Cervical Dystonia
|
N/A | |
Recruiting |
NCT06117020 -
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
|
Phase 1 | |
Completed |
NCT01432899 -
Studying Childhood-Onset Hemidystonia
|
||
Completed |
NCT04948684 -
Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism
|
||
Completed |
NCT05106816 -
The Effects of Vibrotactile Stimulation in Patients With Movement Disorders
|
N/A | |
Recruiting |
NCT05027997 -
Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm
|
Phase 2 | |
Completed |
NCT00465790 -
Research of Biomarkers in Parkinson Disease
|
Phase 0 | |
Active, not recruiting |
NCT00142259 -
Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia
|
Phase 4 | |
Recruiting |
NCT05663840 -
Effects of Exercise on Dystonia Pathophysiology
|
N/A | |
Not yet recruiting |
NCT06038097 -
Efficacy and Safety of Radiofrequency Pallidotomy in the Management of Dystonia
|
N/A | |
Recruiting |
NCT04286308 -
Cortical-Basal Ganglia Speech Networks
|
N/A | |
Active, not recruiting |
NCT03582891 -
The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy
|
N/A | |
Completed |
NCT03318120 -
Exercise Training in Dystonia
|
N/A | |
Completed |
NCT04568681 -
Deep Brain Stimulation Effects in Dystonia
|